1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

  • February 2017
  • -
  • International Market Analysis Research and Consult
  • -
  • 49 pages

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japan diabetes market in any form.

What we have achieved in this report?

Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in Japan
Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
Historical, current and future prevalence of diabetes among males and females in Japan
Historical, current and future prevalence of diabetes among various age groups in Japan
Historical, current and future diagnosis rates for diabetes in Japan
Historical, current and future drug treatment rates for diabetes in Japan

Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in Japan
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the Japanese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in Japan
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in Japan
Market Segmentation
Key players
Market outlook 

Table Of Contents

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
1 Preface
2 Research Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 Japan Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Japan Diabetes Market
7.1 Market Overview 
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter's Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 Japan Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 Japan Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
7.8 Competitive Landscape
7.8.1 Competitive Structure
7.8.2 Profiles of Key Players

List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 and 2035
Figure 4: Japan: Overweight and Obese Population* (in Million), 2010, 2016 and 2022
Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 6: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 and 65+), (in %)
Figure 7: Japan: Diabetes Prevalence By Age Groups, (in %)
Figure 8: Japan: Total Number of Diabetes Patients* (in 000), 2009-2016
Figure 9: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2017-2022
Figure 10: Japan (Type1 and Type2): Total Number of Diabetes Patients* (in 000), 2009- 2016
Figure 11: Japan (Type1 and Type2): Total Number of Diabetes Patients* (in 000), 2017-2022
Figure 12: Japan (Urban and Rural): Total Number of Diabetes Patients* (in 000), 2009 -2022
Figure 13: Japan (Urban and Rural): Total Number of Diabetes Patients* (in 000), 2017 - 2022
Figure 14: Japan (Male and Female): Total Number of Diabetes Patients* (in 000), 2009 - 2016
Figure 15: Japan (Male and Female): Total Number of Diabetes Patients* (in 000), 2017 - 2022
Figure 16: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in 000), 2009 - 2016
Figure 17: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in 000), 2017 - 2022
Figure 18: Japan: Diabetes Drug Industry Overview
Figure 19: Japan: Diabetes Drug Market (in Million US$), 2009 - 2016
Figure 20: Japan: Diabetes Drug Market Forecast (in Million US$), 2017 - 2022
Figure 21: Japan: Diabetes Drug Market: SWOT Analysis
Figure 22: Japan: Diabetes Drug Market: Value Chain Analysis
Figure 23: Japan: Diabetes Drug Market: Porters Five Forces Analysis
Figure 24: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
Figure 25: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
Figure 26: Japan: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
Figure 27: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 and 2016
Figure 28: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 29: Japan: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
Figure 30: Japan: Insulin Market, (in Million US$), 2009 - 2016
Figure 31: Japan: Breakup of Insulin Market by Class (in %)
Figure 32: Japan: Insulin Market: Sales Share of Key Players (in %)
Figure 33: Japan: Insulin Market Forecast (in Million US$), 2017 - 2022

List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2016 and 2035
Table 3: Japan: Overweight andObesity Statistics, 2010, 2016 and 2022
Table 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 and 65+), (in Million)
Table 5: Japan: Total Prevalence and Number of Diabetes Patients*, 2009, 2016 and 2022
Table 6: Japan (Type1 and Type2): Total Prevalence and Number of Diabetes Patients, 2009, 2016 and 2022
Table 7: Japan (Urban and Rural): Total Prevalence and Number of Diabetes Patients, 2009, 2016 and 2022
Table 8: Japan (Male and Female): Total Prevalence and Number of Diabetes Patients, 2009, 2016 and 2022
Table 9: Japan: Total Prevalence and Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (In Millions), 2009, 2016 and 2022
Table 10: Japan: Diabetes Drug Market: Competitive Structure

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Diabetes Injection Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Diabetes Injection Pens Market: Overview This report on diabetes injection pens market studies the current as well as future prospects of the market globally. The stakeholders of this report include ...

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Diabetic Gastroparesis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Diabetic Gastroparesis fo ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.